JMJD1C and glioblastoma: Furthermore, they found that JMJD1C in GBM cells upregulates miR-302a by promoting H3K9 demethylation at the promoter region, and then miR-302a targets the methyltransferase-like 3 (METTL3) 3′UTR to negatively regulate its expression.